APTEVO RES AND DEV LLC has a total of 15 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2008. It filed its patents most often in China, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are APTEVO RES & DEVELOPMENT LLC, INTERNAT DRUG DEV BIOTECH and BIOSION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Hungary | 1 | |
#7 | Malaysia | 1 | |
#8 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Blankenship John W | 8 |
#2 | Tan Philip | 7 |
#3 | Blankenship John | 4 |
#4 | Thompson Peter Armstrong | 4 |
#5 | Natarajan Sateesh Kumar | 4 |
#6 | Sewell Elaine Todd | 3 |
#7 | Baum Peter Robert | 3 |
#8 | Lowe Richard | 2 |
#9 | Mcmahan Catherine J | 2 |
#10 | Mitchell Danielle | 2 |
Publication | Filing date | Title |
---|---|---|
CN109952112A | CD123 binding protein and relevant composition and method | |
EP3119902A1 | Cell line-based redirected t-cell cytotoxicity assay |